HOME >> BIOLOGY >> NEWS
Cloning chip

A CHIP that will automatically create hundreds of cloned embryos at a time is being developed by a Californian biotech company, New Scientist has learned.

If it lives up to its promise, the chip should help make cloning cheap and easy enough for companies to mass-produce identical copies of the best milk or meat producing animals for farmers. It might even be used for cloning human embryos.

The chip automates the laborious process of nuclear transfer, the key step in cloning. At present it takes hours of painstaking work with a microscope to remove the nucleus of an egg cell and replace it by fusing the denucleated egg with another cell.

"If somebody's got something like that, obviously it would make everybody's life easier," says Tanja Dominko of Advanced Cell Technology, the Massachusetts company that caused a stir late last year when it announced that it had created cloned human embryos.

In animals, cloning is still very wasteful. At best, around half of cloned embryos develop to the point where they can be implanted, and only a tenth of these survive to birth. Often more than a hundred nuclear transfers must be carried out to create a single clone.

Scientists usually start with a batch of 150 eggs, and denucleate them one at a time before moving on to the next step. That means eggs can be left sitting around for several hours, a delay that may reduce success rates.

But the nuclear transfer array developed at Aegen Biosciences, by the company's founders Richard Kuo and Gregory Baxter, could handle hundreds or even thousands of eggs at once. Kuo says they can routinely denucleate 30 to 50 sea urchin eggs at a time. They plan to start testing cow eggs in the next few weeks.

The prototype is a thin silicon slice a few centimetres across etched with hundreds of tiny wells, one for each egg. The trick is to spin the chip in a centrifuge, forcing the eggs' dense nuclei through a small hole at the bottom of each well. About 9
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
30-Jan-2002


Page: 1 2 3

Related biology news :

1. Cloning pigs and drug discovery among hot topics
2. Cloning primates is turning out to be a real challenge
3. Cloning can turn back the developmental clock
4. Cloning reverses aging in cow cells, Scienceauthors say
5. Cloning reverses aging in cow cells, a milestone in medical research
6. First Reproducible Cloning Of Mammals From Adult Cells Reported In Nature
7. Human Cloning: Grappling With Reality Penn Bioethicist To Explore The Facts Behind The Hysteria
8. The Cloning of Humans On The Adoption Model: Penn Bioethicist Will Present A Model For Future Laws Involving Human Cloning
9. UNESCO Director-General Reaffirms That Human Cloning Is Contrary To Human Dignity
10. Human Cloning: International Bioethics Committee President Stresses Political And Moral Commitment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cloning chip

(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced ... India 2015-2019" report to their offering. ... market is the adoption of multimodal biometric systems. ... of an individual for verification and identification purposes. ...
(Date:12/10/2014)... Forest Baptist Medical Center today announced plans for a ... Funding for this $50 million capital project is part ... launched next summer. The medical education ... R.J. Reynolds Tobacco Company complex, adjacent to 525@vine in ... plans to be ready to welcome medical students in ...
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
(Date:12/19/2014)... Dec. 18, 2014 Relmada Therapeutics, Inc. (OTCQB: ... treatment of chronic pain, announced the results of its ... "This was a transformational year in Relmada,s history and ... our company," said Sergio Traversa , chief executive ... executed on key financial, human resource and clinical development ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 Audacity, ... activation agency and member of the Huntsworth Health Group, ... to its executive team. In her role, Gonzales will ... , “We are incredibly honored to welcome a talent ... Chief and CEO, Gaëtan Fraikin. “She is a proven ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
Cached News: